Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: borredo

$2.90 or more...BLunist & kidd

posted on Nov 14, 2007 04:21AM

You guys have this friendly argument about realistic expectations for the PPS, and it hinges on P/E multiples. Yes, our current P/E is 14.33 based on last reported financials.

Then you talk of a P/E of 24, and other off-the-wall numbers.

The average P/E in our industry is 39. RMBS P/E is 57. With even a modest settlement, should not our P/E at least rise to the average? Is it average for a company with no debt, very low overhead, and 5 employees, and windfall of at least $100M and 450+ infringers-in-waiting to be considered "average"?

This is why I posed the question the other day about the relevance of Market Caps. It seems every time I do any calculations involving what I consider realistic P/Es, I bump my head on an outrageous market cap.

But I'll offer this: $200M settlement with the Js, $100M to PTSC, better than 25 cents per share earnings on this alone, apply a more realistic P/E multiple of 40 (a hair above "average") = $10/share.

I now reiterate my question re: market caps - relevant? Is RMBS's P/E realistic? Their ~$2B market cap?

JMHOs, and I obviously KNOW nuttin'!

SGE

Share
New Message
Please login to post a reply